
About Wanbury Pharma Limited
Data last updated:
Wanbury Pharma Limited is a public limited company based in Navi Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 31 October 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U33119MH2012PLC237381. Its GSTIN is 27AABCW3130H1ZK (Maharashtra).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹5 Lakh. It is led by directors including Vijaykumar Shivaji Ayare and Venkat Kumar Ketha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D – 28/11 MIDC Ttc Industrial Area Turbhe, Navi Mumbai, Maharashtra, India – 400706.
The company is associated with 1 brand: Wanbury Limited.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website wanbury.com.
Company details
Contact details
Wanbury Pharma Limited's registered office is in Navi Mumbai, Maharashtra. Its website is wanbury.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressD – 28/11 MIDC Ttc Industrial Area Turbhe, Navi Mumbai, Maharashtra, India – 400706
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Wanbury Pharma Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Wanbury Pharma operates one associated brand: Wanbury Limited. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Anti-diabetic drugs and active pharmaceutical ingredients are manufactured. | wanbury.com |
Financials of Wanbury Pharma Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Wanbury Pharma Limited, buy the company report.
Board of directors of Wanbury Pharma Limited
Wanbury Pharma has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vijaykumar Shivaji Ayare Also directs: Parnax Lab Limited | Director | 31 Oct 2012 | 14 Years 0 Months | Current |
| Venkat Kumar Ketha Also directs: Expert Chemicals (India) Private Limited, Metallica Enterprise Private Limited, Omkar Logistics Private Limited and 1 more | Director | 15 Dec 2022 | 3 Years 11 Months | Current |
| Sunil Vasudev Kotyankar Also directs: Wanbury Skin Health Limited, Expert Chemicals (India) Private Limited, Bravo Healthcare Limited and 3 more | Director | 15 Dec 2022 | 3 Years 11 Months | Current |
Auditor
Wanbury Pharma Limited is audited by KAPOOR & PAREKH ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KAPOOR & PAREKH ASSOCIATES | FY 2022 | 104803W |
Shareholding
The shareholding of Wanbury Pharma Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Wanbury Pharma Limited, buy the company report.
Legal cases
No court or tribunal cases involving Wanbury Pharma Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Wanbury Pharma Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Wanbury Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCW3130H1ZK | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Wanbury Pharma Limited, buy the company report.
Recent activity
Wanbury Pharma Limited has 7 board changes on record since 2012: 3 appointments and 4 cessations. The latest: Sunil Vasudev Kotyankar was appointed as Director on 15 Dec 2022.
News
Frequently asked questions
Wanbury Pharma is an active public limited company based in Navi Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 31 October 2012 (14+ years old) and is registered under CIN U33119MH2012PLC237381.
Wanbury Pharma has 3 current directors:
- Vijaykumar Shivaji Ayare - Director
- Venkat Kumar Ketha - Director
- Sunil Vasudev Kotyankar - Director
The latest financial statements of Wanbury Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Wanbury Pharma is 27AABCW3130H1ZK, registered in Maharashtra.
The CIN (Corporate Identification Number) of Wanbury Pharma is U33119MH2012PLC237381. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Wanbury Pharma was incorporated on 31 October 2012, making it 14+ years old. It is registered with the Registrar of Companies, Mumbai.
Sunil Vasudev Kotyankar was appointed as Director on 15 Dec 2022. Venkat Kumar Ketha was appointed as Director on 15 Dec 2022. Ravikant Keshav Alhat ceased to be Additional Director on 30 Sep 2016. Wanbury Pharma has 7 board changes on record in total.
Wanbury Pharma can be reached through the website wanbury.com. Its registered office is in Navi Mumbai, Maharashtra, India.
The registered office of Wanbury Pharma is at D – 2811 MIDC Ttc Industrial Area Turbhe, Navi Mumbai, Maharashtra, India – 400706.
Wanbury Pharma operates in the pharma industry, in the drug formulation and development segment.

